The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Supply Chain Strategies & Solutions Article
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based valu
Toolkits/Methodology
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Guides and Reports
In 2001 the Institute of Medicine (IOM) published